Cargando…
Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy
Mesenchymal stem/stromal cell (MSC)-based therapy has become an attractive and advanced scientific research area in the context of cancer therapy. This interest is closely linked to the MSC-marked tropism for tumors, suggesting them as a rational and effective vehicle for drug delivery for both hema...
Autores principales: | Hassanzadeh, Ali, Altajer, Amjad Hussein, Rahman, Heshu Sulaiman, Saleh, Marwan Mahmood, Bokov, Dmitry O., Abdelbasset, Walid Kamal, Marofi, Faroogh, Zamani, Majid, Yaghoubi, Yoda, Yazdanifar, Mahboubeh, Pathak, Yashwant, Chartrand, Max Stanley, Jarahian, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311597/ https://www.ncbi.nlm.nih.gov/pubmed/34322483 http://dx.doi.org/10.3389/fcell.2021.686453 |
Ejemplares similares
-
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021) -
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
por: Marofi, Faroogh, et al.
Publicado: (2021) -
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
por: Marofi, Faroogh, et al.
Publicado: (2021) -
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021) -
CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021)